Verbruggen, A.M. et al., "Technetium-99m-L,L-Ethylenedicysteine: A Renal Imaging Agent. I. Labeling and Evaluation in Animals," J. Nuclear Medicine (Apr. 1992) 33(4):551-557. |
Taylor, A., Jr. et al., "Technetium-99m MAG.sub.3 Kit Formulation: Preliminary Results in Normal Volunteers and Patients with Renal Failure," J. Nuclear Medicine (May 1988) 29(5):616-622. |
Shattuck, L.A. et al., "Evaluation of the Hepatobiliary Excretion of Technetium-99m-MAG3 and Reconstitution Factors Affecting Radiochemical Purity," J. Nuclear Medicine (Feb. 1994) 35(2):349-355. |
Verbruggen, A. et al., "Evaluation of the Diastereomers of Tc-99m-Mercaptoace-Tylglycyl-D-Alanylglycine (Tc-99m-D-MAGAG) in Primates," Proceedings of 35th Annual Meeting, J. Nuclear Medicine (May 1988) 29(5):909-910. |
Eshima, D. et al., "Animal Evaluation of Technetium-99m Triamide Mercaptide Complexes as Potential Renal Imaging Agents," J. Nuclear Medicine (Jul. 1987) 28(7):1180-1186. |
VanNerom, C. et al., "Comparison of Renal Excretion Characteristics of Isomers L,L and D,D of Tc-99m Ethylenedicysteine," J. Nuclear Medicine, Proceedings of 37th Annual Meeting, p. 806 (1990). |
Bubeck, B. et al., "Pharmacokinetics of Technetium-99m-MAG.sub.3 is Humans," J. Nuclear Medicine (Aug. 1990) 31(8):1285-1293. |